[The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
D000951:Antigens, Neoplasm / Q000032:analysis* / Q000276:immunology; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen / Q000276:immunology; D003937:Diagnosis, Differential; D000939:Epitopes; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000276:immunology; D010195:Pancreatitis / Q000175:diagnosis
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen; D000939:Epitopes
Das tumor-assoziierte Antigen CA 19-9 in der Differentialdiagnostik und Verlaufskontrolle von Malignomen des Pankreas und Magen-Darm-Traktes.